Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies

Author(s):  Maham Nicole Y

Issue:  Nov/Dec 2022 - Volume 26, Number 6
View All Articles in Issue

Page(s):  474-479

Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 1
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 2
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 3
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 4
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 5
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies Page 6

Download in electronic PDF format for $75

Abstract:  Patients’ responses to medical treatment vary greatly; while many may benefit from pharmacological therapy, others may suffer from harmful drug reactions or show no response at all. To provide an effective individualized care, one must understand the elements that lead to varying patient outcomes and how these factors may interplay in an individual’s treatment outcome. Pharmacogenomics is the future of pharmacy, and there is a growing demand for this service. Compounding pharmacies are already at the forefront of meeting patients’ unique drug requirements. This gives them the opportunity to provide their patients with more valuable services than only selling drugs dictated by the formula! This article discusses pharmacogenomics as a competitive strategy for compounding pharmacies.

Related Keywords: Nicole Y. Maham, PharmD Candidate, MS(s) (Biomedical Science and IT Management), BS (Industrial Management), treatment outcomes, pharmacogenomics, drug response, personalized medicine, pharmacokinetics, pharmacodynamics, genetic polymorphism, genome-wide association studies, single-nucleotide polymorphisms, copy number variations, Clinical Pharmacogenomics Implementation Consortium, CPIC, gene-drug pairings, metabolizer phenotypes, pharmacogenomics implementation models, pharmacogenomic counseling, genetic counselors

Related Categories: BUSINESS, MARKETING, TECHNOLOGY, PATIENT ASSESSMENT, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies
Maham Nicole Y
Nov/Dec 2022
Pg. 474-479

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Allen Loyd V
Jul/Aug 2015
Pg. 280-287

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph
, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018
Pg. 95-107

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin
, Carvalho Maria, Banov Fabiana
Nov/Dec 2023
Pg. 468-473

Basics of Pharmacogenomics for the Compounding Pharmacist
Kupiec Thomas C
, Raj Vishnu
Jul/Aug 2005
Pg. 303-306

Pharmacogenomics: The End of Trial-and-Error Medicine?
Vail Jane
Jan/Feb 2007
Pg. 59-65

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Finding the Right Balance: A Nationwide Study of Student Pharmacist Exposure to and Perceptions of Nonsterile Compounding
Fredrickson Mary E
, Belcher Faith G, Del Vecchio Kamryn N, Galleher Miranda N, Jugo Leila S, Gothard M David, Pallotta Raneem H, Pallotta Victor A Jr
May/Jun 2022
Pg. 242-247

Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A
, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021
Pg. 109-113

Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
Jan/Feb 2007
Pg. 56-58

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
Jul/Aug 2020
Pg. 296-297

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Pitch Ointment: Applications in Scar and Wound Management
Kloesel Lawson
, Carvalho Maria, Banov Fabiana
May/Jun 2018
Pg. 182-188

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Sep/Oct 2008
Pg. 414-418

Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P
, Yale Robert N, Corbett Corinne, Litera Natalie
Jul/Aug 2008
Pg. 329-333

Return to Top